Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Physiology of Yersinia pestis.

Brubaker RR.

Adv Exp Med Biol. 2016;918:79-99. Review.

PMID:
27722861
2.

Consequences of missense mutations in Yersinia pestis: efficient flow of metabolic carbon versus virulence.

Brubaker RR.

Adv Exp Med Biol. 2012;954:31-8. doi: 10.1007/978-1-4614-3561-7_4. Review. No abstract available.

PMID:
22782743
3.
4.

Growth of calcium-blind mutants of Yersinia pestis at 37 degrees C in permissive Ca2+-deficient environments.

Fowler JM, Wulff CR, Straley SC, Brubaker RR.

Microbiology. 2009 Aug;155(Pt 8):2509-21. doi: 10.1099/mic.0.028852-0. Epub 2009 May 14.

5.

Pneumonic plague pathogenesis and immunity in Brown Norway rats.

Anderson DM, Ciletti NA, Lee-Lewis H, Elli D, Segal J, DeBord KL, Overheim KA, Tretiakova M, Brubaker RR, Schneewind O.

Am J Pathol. 2009 Mar;174(3):910-21. doi: 10.2353/ajpath.2009.071168. Epub 2009 Jan 22.

6.

Attenuated enzootic (pestoides) isolates of Yersinia pestis express active aspartase.

Bearden SW, Sexton C, Pare J, Fowler JM, Arvidson CG, Yerman L, Viola RE, Brubaker RR.

Microbiology. 2009 Jan;155(Pt 1):198-209. doi: 10.1099/mic.0.021170-0.

PMID:
19118360
7.

A missense mutation causes aspartase deficiency in Yersinia pestis.

Viola RE, Yerman L, Fowler JM, Arvidson CG, Brubaker RR.

Microbiology. 2008 May;154(Pt 5):1271-80. doi: 10.1099/mic.0.2007/015529-0.

PMID:
18451035
8.

Intermediary metabolism, Na+, the low calcium-response, and acute disease.

Brubaker RR.

Adv Exp Med Biol. 2007;603:116-29.

PMID:
17966409
9.

How the structural gene products of Yersinia pestis relate to virulence.

Brubaker RR.

Future Microbiol. 2007 Aug;2(4):377-85. Review.

PMID:
17683274
10.

Attachment of LcrV from Yersinia pestis at dual binding sites to human TLR-2 and human IFN-gamma receptor.

Abramov VM, Khlebnikov VS, Vasiliev AM, Kosarev IV, Vasilenko RN, Kulikova NL, Khodyakova AV, Evstigneev VI, Uversky VN, Motin VL, Smirnov GB, Brubaker RR.

J Proteome Res. 2007 Jun;6(6):2222-31. Epub 2007 Apr 19.

PMID:
17441749
11.

LcrV plague vaccine with altered immunomodulatory properties.

Overheim KA, Depaolo RW, Debord KL, Morrin EM, Anderson DM, Green NM, Brubaker RR, Jabri B, Schneewind O.

Infect Immun. 2005 Aug;73(8):5152-9.

13.

Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis.

Chain PS, Carniel E, Larimer FW, Lamerdin J, Stoutland PO, Regala WM, Georgescu AM, Vergez LM, Land ML, Motin VL, Brubaker RR, Fowler J, Hinnebusch J, Marceau M, Medigue C, Simonet M, Chenal-Francisque V, Souza B, Dacheux D, Elliott JM, Derbise A, Hauser LJ, Garcia E.

Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13826-31. Epub 2004 Sep 9.

14.

Temporal global changes in gene expression during temperature transition in Yersinia pestis.

Motin VL, Georgescu AM, Fitch JP, Gu PP, Nelson DO, Mabery SL, Garnham JB, Sokhansanj BA, Ott LL, Coleman MA, Elliott JM, Kegelmeyer LM, Wyrobek AJ, Slezak TR, Brubaker RR, Garcia E.

J Bacteriol. 2004 Sep;186(18):6298-305.

15.

The recent emergence of plague: a process of felonious evolution.

Brubaker RR.

Microb Ecol. 2004 Apr;47(3):293-9. Epub 2004 Mar 25. Review.

PMID:
15037962
16.

Evolutionary genetics: CCR5 mutation and plague protection.

Mecsas J, Franklin G, Kuziel WA, Brubaker RR, Falkow S, Mosier DE.

Nature. 2004 Feb 12;427(6975):606.

PMID:
14961112
17.

Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen).

Brubaker RR.

Infect Immun. 2003 Jul;71(7):3673-81. Review. No abstract available.

18.

Genome sequence of Yersinia pestis KIM.

Deng W, Burland V, Plunkett G 3rd, Boutin A, Mayhew GF, Liss P, Perna NT, Rose DJ, Mau B, Zhou S, Schwartz DC, Fetherston JD, Lindler LE, Brubaker RR, Plano GV, Straley SC, McDonough KA, Nilles ML, Matson JS, Blattner FR, Perry RD.

J Bacteriol. 2002 Aug;184(16):4601-11.

19.

Genetic variability of Yersinia pestis isolates as predicted by PCR-based IS100 genotyping and analysis of structural genes encoding glycerol-3-phosphate dehydrogenase (glpD).

Motin VL, Georgescu AM, Elliott JM, Hu P, Worsham PL, Ott LL, Slezak TR, Sokhansanj BA, Regala WM, Brubaker RR, Garcia E.

J Bacteriol. 2002 Feb;184(4):1019-27.

20.

Detection of Yersinia pestis by pesticin fluorogenic probe-coupled PCR.

Iqbal SS, Chambers JP, Goode MT, Valdes JJ, Brubaker RR.

Mol Cell Probes. 2000 Apr;14(2):109-14.

PMID:
10799272
21.

Detection of Yersinia pestis using branched DNA.

Iqbal SS, Chambers JP, Brubaker RR, Goode MT, Valdes JJ.

Mol Cell Probes. 1999 Aug;13(4):315-20.

PMID:
10441205
22.

Molecular characterization of KatY (antigen 5), a thermoregulated chromosomally encoded catalase-peroxidase of Yersinia pestis.

Garcia E, Nedialkov YA, Elliott J, Motin VL, Brubaker RR.

J Bacteriol. 1999 May;181(10):3114-22.

23.

For Pseudomonas aeruginosa, stealth is no longer enough.

Brubaker RR.

Nat Med. 1999 Apr;5(4):378-9. No abstract available.

PMID:
10202921
24.

Expression of the plague plasminogen activator in Yersinia pseudotuberculosis and Escherichia coli.

Kutyrev V, Mehigh RJ, Motin VL, Pokrovskaya MS, Smirnov GB, Brubaker RR.

Infect Immun. 1999 Mar;67(3):1359-67.

25.

Structural organization of virulence-associated plasmids of Yersinia pestis.

Hu P, Elliott J, McCready P, Skowronski E, Garnes J, Kobayashi A, Brubaker RR, Garcia E.

J Bacteriol. 1998 Oct;180(19):5192-202.

26.

Suppression of mouse skin allograft rejection by protein A-Yersiniae V antigen fusion peptide.

Motin VL, Kutas SM, Brubaker RR.

Transplantation. 1997 Apr 15;63(7):1040-2.

PMID:
9112365
28.

V antigen-polyhistidine fusion peptide: binding to LcrH and active immunity against plague.

Motin VL, Nedialkov YA, Brubaker RR.

Infect Immun. 1996 Oct;64(10):4313-8.

29.

Iron uptake and iron-repressible polypeptides in Yersinia pestis.

Lucier TS, Fetherston JD, Brubaker RR, Perry RD.

Infect Immun. 1996 Aug;64(8):3023-31.

30.
31.

Physiological basis of the low calcium response in Yersinia pestis.

Fowler JM, Brubaker RR.

Infect Immun. 1994 Dec;62(12):5234-41. Erratum in: Infect Immun 1995 Apr;63(4):1615.

32.

Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide.

Motin VL, Nakajima R, Smirnov GB, Brubaker RR.

Infect Immun. 1994 Oct;62(10):4192-201.

33.

Storage reservoirs of hemin and inorganic iron in Yersinia pestis.

Perry RD, Lucier TS, Sikkema DJ, Brubaker RR.

Infect Immun. 1993 Jan;61(1):32-9.

36.

Factors promoting acute and chronic diseases caused by yersiniae.

Brubaker RR.

Clin Microbiol Rev. 1991 Jul;4(3):309-24. Review.

37.

The V antigen of yersiniae: an overview.

Brubaker RR.

Contrib Microbiol Immunol. 1991;12:127-33. Review. No abstract available.

PMID:
1935079
38.

Expression of the low calcium response in Yersinia pestis.

Mehigh RJ, Sample AK, Brubaker RR.

Microb Pathog. 1989 Mar;6(3):203-17.

PMID:
2739560
39.
40.
41.

Transport of Ca2+ by Yersinia pestis.

Perry RD, Brubaker RR.

J Bacteriol. 1987 Oct;169(10):4861-4.

42.
43.

Modulation of the low-calcium response in Yersinia pestis via plasmid-plasmid interaction.

Sample AK, Fowler JM, Brubaker RR.

Microb Pathog. 1987 Jun;2(6):443-53.

PMID:
3507558
44.
45.

Roles of V antigen in promoting virulence in Yersiniae.

Une T, Nakajima R, Brubaker RR.

Contrib Microbiol Immunol. 1987;9:179-85. No abstract available.

PMID:
3665496
46.

Proteolysis of V antigen from Yersinia pestis.

Brubaker RR, Sample AK, Yu DZ, Zahorchak RJ, Hu PC, Fowler JM.

Microb Pathog. 1987 Jan;2(1):49-62.

PMID:
2853272
47.

Interactions between host cells and yersiniae.

Brubaker RR.

Ann Inst Pasteur Microbiol (1985). 1986 May-Jun;137A(3):321-5. No abstract available.

PMID:
3426159
48.

Mechanisms of bacterial virulence.

Brubaker RR.

Annu Rev Microbiol. 1985;39:21-50. Review.

PMID:
3904601
49.

Roles of V antigen in promoting virulence and immunity in yersiniae.

Une T, Brubaker RR.

J Immunol. 1984 Oct;133(4):2226-30.

PMID:
6381597
50.

Supplemental Content

Loading ...
Support Center